304 related articles for article (PubMed ID: 12280954)
1. Norplant update.
Netw Res Triangle Park N C; 1988; 9(2):8. PubMed ID: 12280954
[TBL] [Abstract][Full Text] [Related]
2. Another view on Norplant: match method with users.
Herndon N
Netw Res Triangle Park N C; 1992 Oct; 13(2):24-6. PubMed ID: 12286081
[TBL] [Abstract][Full Text] [Related]
3. Contraceptive retail surveys locate problems of acceptance.
Netw Res Triangle Park N C; 1985; 6(4):6-7. PubMed ID: 12340326
[TBL] [Abstract][Full Text] [Related]
4. [Contraceptive development--the view from the U.S.A. in the mid 80s].
Potts M; Siemens A; Burton N
Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
[TBL] [Abstract][Full Text] [Related]
5. NORPLANT contraceptive implants advancing.
Segal SJ
Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
[TBL] [Abstract][Full Text] [Related]
6. Postmarketing surveillance in developing countries.
Meirik O
Netw Res Triangle Park N C; 1988; 9(2):6. PubMed ID: 12280953
[TBL] [Abstract][Full Text] [Related]
7. Postmarketing evaluations help determine contraceptive safety, efficacy.
Netw Res Triangle Park N C; 1988; 9(2):1-2, 7. PubMed ID: 12280950
[TBL] [Abstract][Full Text] [Related]
8. Hearing focuses on price of Norplant; Wyeth pledges discount for public sector.
Wash Memo Alan Guttmacher Inst; 1993 Nov; (18):3-4. PubMed ID: 12318533
[TBL] [Abstract][Full Text] [Related]
9. Depo Provera: still controversial.
Wren LM
Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
[TBL] [Abstract][Full Text] [Related]
10. FDA review panel gives thumbs up to Norplant.
Wash Memo Alan Guttmacher Inst; 1989 May; ():3-5. PubMed ID: 12290752
[TBL] [Abstract][Full Text] [Related]
11. [Norplant contraceptive method gains ground. Approved for distribution in the United States].
Pop Sahel; 1990 Dec; (15):55-6. PubMed ID: 12283990
[TBL] [Abstract][Full Text] [Related]
12. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620
[TBL] [Abstract][Full Text] [Related]
13. Wyeth-Ayerst to reduce U.S. price of Norplant implants, but not until December 1995. Family planners outraged.
Contracept Technol Update; 1994 Jan; 15(1):1-3. PubMed ID: 12319213
[TBL] [Abstract][Full Text] [Related]
14. FHI quinacrine studies.
Family Health International FHI
Netw Res Triangle Park N C; 1995 Sep; 16(1):27. PubMed ID: 12290470
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive research: still inadequate after all these years?
Diconsiglio JM
Family Plan World; 1992; 2(6):14. PubMed ID: 12344623
[TBL] [Abstract][Full Text] [Related]
16. Condoms becoming more popular.
Manuel J
Netw Res Triangle Park N C; 1993 May; 13(4):22-4. PubMed ID: 12344872
[TBL] [Abstract][Full Text] [Related]
17. Social marketing program sales.
Soc Mark Forum; 1984; 1(4):6-7. PubMed ID: 12266334
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of IUDs is increasing.
Finger WR; Barr D
Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
[TBL] [Abstract][Full Text] [Related]
19. Norplant may be too costly for low income women.
Family Plan World; 1991; ():7, 14. PubMed ID: 12346943
[TBL] [Abstract][Full Text] [Related]
20. Vaginal contraceptives: worldwide use remains low but methods have potential.
Netw Res Triangle Park N C; 1986; 7(2):1, 5. PubMed ID: 12340618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
